All Sauce from Weekly Sauce:

Suicide rates for Black women and girls ages 15 to 24 have more than doubled over the past two decades, a new report finds. “Suicides are rapidly increasingly among young, Black females in the U.S.,” said study first author Victoria Joseph, an analyst in the department of epidemiology at Columbia Mailman School of Public Health…  read on >  read on >

Games like football, soccer and rugby come to mind when thinking about sports-related concussions. But a smashing tennis shot could cause a traumatic brain injury if the ball whacks a player’s head, a new study argues. Concussions can happen if a tennis ball traveling faster than 89 miles per hour hits someone on the head,…  read on >  read on >

“Forever” PFAS chemicals appear to harm bone health in Hispanic teenagers, a new study finds. The more PFAS chemicals found in the bodies of Hispanic adolescents, the lower their bone density was, researchers report in the Dec. 6 issue of the journal Environmental Research. Peak bone mineral density in adolescence helps predict whether a person…  read on >  read on >

A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin, slowing progression of the disease. Type 1 diabetes comprises about 5% of…  read on >  read on >

Acne can be terribly embarrassing for a teenager, but a new study has found that adults’ blemishes might have even greater consequences for their social and professional reputation. People are less likely to want to be friends, have close contact or post a pic on social media with a person who has severe acne, researchers…  read on >  read on >

The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. “Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound,” Rhonda Pacheco, group vice president of Lilly Diabetes and Obesity, U.S., said in a company news…  read on >  read on >